🧾 Poster #487
Data-Driven Characterization of Heterogeneous Brain Atrophy and White Matter Hyperintensity Progression in FTD (Amelie Metz @ameliemetz.bsky.social )
Tuesday, July 29

🧾 Poster #408 (also shown at AIC-274)
Time-dependent biomarker accuracy in forecasting MCI (Jonathan Gallego Rudolf)
Tuesday, July 29

🧾 Poster #020
Daridorexant for Alzheimer’s Disease Prevention – Upcoming Clinical Trial (Nolan-Patrick Cunningham)
Tuesday, July 29

🧾 Poster #981
Spatiotemporal associations between amyloid and tau pathologies (Alfonso Fajardo-Valdez)
Monday, July 28

🧾 Poster #975
Multi-echo resting-state fMRI processing of the PREVENT-AD cohort (Mohammadali Javanray)
Monday, July 28

🧾 Poster #305 (also at AIC-076)
Comparison of Longitudinal Plasma Assays and Amyloid Pathology (Yara Yakoub @yarayakoub.bsky.social)
Monday, July 28

⭐ Featured Research Session
Sex-specific effects of neuropsychiatric symptoms on amyloid and tau pathology and WMH volume in preclinical AD (Aurélie Garrone)
Monday, July 28 – 8:00–8:45 AM | Room 107

🧾 Poster #433
The role of tau and amyloid pathology in neurosensory impairments (Daniel Bowie @bovvie.bsky.social )
Sunday, July 27

🧾 Poster #410 (also at AIC-322)
Tracking structural changes in preclinical and prodromal Alzheimer’s disease (Ting Qiu)
Sunday, July 27

🧾 Poster #371
Vascular risk factors modulate the association between amyloid and tau PET (Valentin Ourry)
Sunday, July 27

⚡ Lightning Presentation
Tracking structural changes in preclinical and prodromal Alzheimer’s disease (Ting Qiu)
Sunday, July 27, 8:00–8:45 AM | Room 701

🗣️ Plenary Talk
Biomarker and Clinical Trajectories of Preclinical AD (Dr. Sylvia Villeneuve @sylviavilleneuve.bsky.social )
Sunday, July 27, 11:00 AM